BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
US Department of Justice
Merck
Express Scripts
UBS
Medtronic
Colorcon
Farmers Insurance
Fuji

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,955,619

« Back to Dashboard

Summary for Patent: 7,955,619
Title:Abuse resistant drugs, method of use and method of making
Abstract: An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprises a drug that is substantially homogeneously distributed within the second polymer and diffuses from the diffusion layer within the gastrointestinal (GI) tract; and optionally an expansion layer comprising an expandable polymer, wherein the expansion layer is substantially covered by the barrier layer. Methods of making the same and methods of using the same are also provided.
Inventor(s): Shah; Manish S. (Valley Cottage, NY), Difalco; Ray J. (Valley Cottage, NY)
Assignee: Inspirion Delivery Technologies, LLC (Valley Cottage, NY)
Application Number:12/950,819
Patent Claim Types:
see list of patent claims
Composition; Process; Formulation; Dosage form;

Drugs Protected by US Patent 7,955,619

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Daiichi Sankyo Inc MORPHABOND ER morphine sulfate TABLET, EXTENDED RELEASE;ORAL 206544-001 Oct 2, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Daiichi Sankyo Inc MORPHABOND ER morphine sulfate TABLET, EXTENDED RELEASE;ORAL 206544-002 Oct 2, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Daiichi Sankyo Inc MORPHABOND ER morphine sulfate TABLET, EXTENDED RELEASE;ORAL 206544-003 Oct 2, 2015 RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Daiichi Sankyo Inc MORPHABOND ER morphine sulfate TABLET, EXTENDED RELEASE;ORAL 206544-004 Oct 2, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Daiichi Sankyo Inc ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-001 Apr 20, 2017 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Daiichi Sankyo Inc ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-002 Apr 20, 2017 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Daiichi Sankyo Inc ROXYBOND oxycodone hydrochloride TABLET;ORAL 209777-003 Apr 20, 2017 RX No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,955,619

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Mexico 336789 ➤ Subscribe
Mexico 2010001812 ➤ Subscribe
Japan 2016138126 ➤ Subscribe
Japan 5965583 ➤ Subscribe
Japan 2010536770 ➤ Subscribe
European Patent Office 2331080 ➤ Subscribe
European Patent Office 2187873 ➤ Subscribe
China 105534936 ➤ Subscribe
China 101801350 ➤ Subscribe
Canada 2923102 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Army
Cipla
Farmers Insurance
Merck
Fish and Richardson
Moodys
Dow
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot